Ascendia Pharmaceutical Solutions

Ascendia Pharmaceutical Solutions

Ascendia Pharmaceutical Solutions

About the plant

Ascendia Pharmaceutical Solutions´ expansive 60,000 square-foot state-of-the-art facility in North Brunswick, New Jersey, has sterile and non-sterile manufacturing capabilities for small molecule and biologic projects. Manufacturing is housed in the same location as our formulation development, analytical testing, and other services, creating a convenient "one-stop shop" for numerous benefits for clients.

Visit our website: Ascendia Pharmaceutical Solutions

---

Certifications

• FDA (cGMP)

---

Activity

• FDF / DRUG PRODUCTS, CHEMICAL-SYNTHETIC, BIOLOGICS, COSMETICS, NUTRACEUTICALS, SERVICES, OLIGONUCLEOTIDES manufacturing

---

Features

• Uses: Commercial (Phase IV), Human
• Toxicity (OEB classification): 4 / HPAPI (PDE = 10 - 100 µg/day)
• DEA: Schedule II (high potential for abuse / medical use), Schedule III (lower potential for abuse), Schedule IV (low potential for abuse), Schedule V (lowest potential for abuse)
• BSL: N/A
• Therapeutic areas: (A) Digestive tract and metabolism, (B) Blood and blood forming organs, (C) Cardiovascular system, (D) Dermatologicals, (G) Genito urinary system and sex hormones, (H) Systemic hormonal preparations excl. sex hormones and insulins, (J) Antiinfectives for systemic use, (L) Antineoplastic and immunomodulating agents, (M) Musculoskeletal system, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (R) Respiratory system, (S) Sensory organs, (V09-10) Radiopharmaceuticals, (V06) Nutrients, (V04) Diagnostic agents, (V01) Allergens
• Markets: FDA (USA)

---

Batch Size / Reactor

• Small, Medium, Large

---

Services

• Development services, Manufacturing services

---